Therapy of multiple myeloma. Italian Multiple Myeloma Study Group.
作者信息
Boccadoro M, Avvisati G, Cantonetti M, Cavo-Comotti B M, Frieri R, Gallamini A, Gallone G, Lauta V M, Liberati M, Marmont F
机构信息
Catedra di Ematologia, Turin, Italie.
出版信息
Pathol Biol (Paris). 1990 Oct;38(8):829.
PMID:2274374
Abstract
摘要
相似文献
1
Therapy of multiple myeloma. Italian Multiple Myeloma Study Group.多发性骨髓瘤的治疗。意大利多发性骨髓瘤研究小组。
Pathol Biol (Paris). 1990 Oct;38(8):829.
2
[Monoclonal gammapathy of indeterminate origin and myeloma].意义未明的单克隆丙种球蛋白病与骨髓瘤
Rev Med Liege. 1988 Apr 15;43(8):270-4.
3
Standard therapy versus autologous transplantation in multiple myeloma.
Hematol Oncol Clin North Am. 1997 Feb;11(1):133-46. doi: 10.1016/s0889-8588(05)70419-6.
4
[Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
Rinsho Ketsueki. 1984 Sep;25(9):1380-7.
5
[Results of alternating treatment of multiple myeloma--cytostatics VBMCP and recombinant interferon alfa-2B].[多发性骨髓瘤交替治疗的结果——细胞抑制剂VBMCP与重组干扰素α-2B]
Pol Arch Med Wewn. 1993 Aug;90(2):134-41.
6
Combination therapy of M2-protocol and interferon-alpha as remission induction in refractory multiple myeloma.
Haematologia (Budap). 1991;24(1):9-11.
7
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93.使用长春新碱、卡莫司汀、美法仑、环磷酰胺和泼尼松（VBMCP）交替联合大剂量环磷酰胺及α(2)β干扰素治疗多发性骨髓瘤与VBMCP治疗的比较：东部肿瘤协作组III期研究E5A93的结果
Cancer. 2009 May 15;115(10):2155-64. doi: 10.1002/cncr.24221.
8
Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.研究报告：美法仑、环磷酰胺、长春新碱、泼尼松和卡氮芥联合化疗多发性骨髓瘤
Cancer. 1974 Feb;33(2):533-8. doi: 10.1002/1097-0142(197402)33:2<533::aid-cncr2820330231>3.0.co;2-z.
9
Results and further perspectives of plasmocytoma chemotherapy.
Neoplasma. 1986;33(2):251-8.
10
Melphalan-resistant multiple myeloma: results of treatment according to the M-2 protocol.
Cancer Chemother Pharmacol. 1985;14(3):279-81. doi: 10.1007/BF00258135.
Zotero 插件